Salas Eduardo Rene
SEC insider (Form 3/4/5 filer). CIK 0001924188. Director at ADMA BIOLOGICS, INC. (ADMA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in RAMSEY, NJ.
Companies Salas Eduardo Rene has filed insider reports for
- ADMA BIOLOGICS, INC. (ADMA): Director
- Intra-Cellular Therapies, Inc. (ITCI): Director
Salas Eduardo Rene
CIK: 0001924188
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 9, 2026ADMA
ADMA BIOLOGICS, INC.
AwardDirect10.7K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionDirect1.6K shares at avg. $132.00$207K - Feb 19, 2025ADMA
ADMA BIOLOGICS, INC.
AwardDirect10.9K shares- - Dec 30, 2024ADMA
ADMA BIOLOGICS, INC.
AwardDirectStock Option (right to buy)
20K shares-
1-4 of 4 transactions